
Opinion|Videos|April 16, 2024
Assessing the Cost-Effectiveness of Prescription Digital Therapeutics
Mahsa Salsabili, PharmD, PhD, underscores the potential cost-effectiveness of treatment through the adoption of prescription digital therapeutics, while acknowledging that additional evidence is required to conclusively determine their cost-effectiveness.
Advertisement
Episodes in this series

Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Myqorzo is now available for rare heart condition at a $108,400 annual price
2
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
3
Medicaid tech companies pledge $600 million to help states update systems
4
Study of antibody-Keytruda combination seeds hope for overcoming immune checkpoint inhibitor resistance, use of biomarkers
5






















